These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24315504)

  • 21. Acquiring hepatitis C in prison: the social organisation of injecting risk.
    Treloar C; McCredie L; Lloyd AR;
    Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study.
    Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J
    Int J Drug Policy; 2015 Oct; 26(10):984-91. PubMed ID: 26256938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs.
    Horyniak D; Dietze P; Degenhardt L; Higgs P; McIlwraith F; Alati R; Bruno R; Lenton S; Burns L
    Drug Alcohol Depend; 2013 Oct; 132(3):541-6. PubMed ID: 23664499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
    Iversen J; Wand H; Gonnermann A; Maher L;
    Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
    Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
    Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
    Rose G; Cama E; Brener L; Treloar C
    Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
    Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
    Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
    Lafferty L; Rance J; Treloar C
    Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs.
    Olsen A; Banwell C; Dance P; Maher L
    Int J Drug Policy; 2012 Jul; 23(4):312-8. PubMed ID: 22721571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland.
    McDonald SA; Hutchinson SJ; Palmateer NE; Allen E; Cameron SO; Goldberg DJ; Taylor A
    J Hepatol; 2013 Mar; 58(3):460-6. PubMed ID: 23149064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
    Blackburn NA; Patel RC; Zibbell JE
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of motivational interviewing for reducing injection risk behaviours among people who inject drugs.
    Bertrand K; Roy É; Vaillancourt É; Vandermeerschen J; Berbiche D; Boivin JF
    Addiction; 2015 May; 110(5):832-41. PubMed ID: 25641704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada.
    Fortier E; Høj SB; Sylvestre MP; Artenie AA; Minoyan N; Jutras-Aswad D; Grebely J; Bruneau J
    Int J Drug Policy; 2021 Oct; 96():103439. PubMed ID: 34518099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.